Sunshine Heart Inc (NASDAQ:CHFS) shares were down 14.8% during mid-day trading on Tuesday . The stock traded as low as $3.23 and last traded at $3.41. Approximately 3,764,919 shares traded hands during mid-day trading, an increase of 536% from the average daily volume of 591,634 shares. The stock had previously closed at $4.00.
Separately, Zacks Investment Research raised Sunshine Heart from a “hold” rating to a “buy” rating and set a $4.00 target price for the company in a research report on Monday, January 8th.
The company has a market cap of $7.34, a PE ratio of -0.02 and a beta of 2.31.
About Sunshine Heart
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with MarketBeat.com's FREE daily email newsletter.